Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically

John L. Frater, Karen F. McCarron, Jeffrey P. Hammel, Joel L. Shapiro, Michael L. Miller, Raymond R. Tubbs, James Pettay, Eric D. Hsi

Research output: Contribution to journalArticlepeer-review

61 Scopus citations


We compared the features of 17 cases of atypical chronic lymphocytic leukemia (aCLL) with those of a clinical control group of 24 cases of CLL. Quantitative flow cytometric data, available for 12 cases, were compared with an immunophenotypic control group of 58 cases using a relative fluorescence index for CD5, CD23, CD79b, and surface immunoglobulin light chain (sIg). Compared with the clinical control group, patients with aCLL had a higher mean WBC count and a lower platelet count. Patients with aCLL had a significantly higher probability of disease progression. Compared with an immunophenotypic control group of 58 CLL cases, 12 cases of aCLL demonstrated significantly higher expression of CD23. There was no significant difference in expression of sIg, CD79b, or CD5 between the groups. CD38 expression was noted in only 1 (9%) of 11 tested cases; 2 (18%) of 11 cases had trisomy 12. aCLL can be distinguished from typical CLL morphologically, clinically, and immunophenotypically. Atypical morphologic features in CLL seem to be a marker of aggressive clinical behavior.

Original languageEnglish
Pages (from-to)655-664
Number of pages10
JournalAmerican journal of clinical pathology
Issue number5
StatePublished - Dec 1 2001


  • Atypical chronic lymphocytic leukemia
  • Chronic lymphocytic leukemia
  • Flow cytometry
  • Fluorescence in situ hybridization
  • Polymerase chain reaction


Dive into the research topics of 'Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically'. Together they form a unique fingerprint.

Cite this